Bacterial dispersal associated with speech in the setting of intravitreous injections

Archives of Ophthalmology

Volumn 129, Issue 12, 2011, Pages 1551-1554

  Wen, Joanne C ^a,b,c   McCannel, Colin A ^a,b,c   Mochon, A Brian ^c   Garner, Omai B ^c  

^a JULES STEIN EYE INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR;

ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM COLONY; BACTERIUM IDENTIFICATION; COMPARATIVE STUDY; EYE EXAMINATION; FACE MASK; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN EXPERIMENT; NEISSERIA; PRIORITY JOURNAL; SPEECH; STAPHYLOCOCCUS; STREPTOCOCCUS;

BACTERIA; BACTERIAL INFECTIONS; COLONY COUNT, MICROBIAL; ENDOPHTHALMITIS; EQUIPMENT CONTAMINATION; EYE INFECTIONS, BACTERIAL; HUMANS; INTRAVITREAL INJECTIONS; MASKS; MOUTH; PHARMACEUTICAL PREPARATIONS; RESPIRATORY SYSTEM; SPEECH;

EID: 83455236535     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.227     Document Type: Article

References (26)

1. Bhavsar AR, Tornambe PE. 25 Years of progress in the treatment of retinal diseases: where we have been, where we are now, and where we will be. Retina. 2006;26(6)(suppl):S1-S6. (Pubitemid 44620341)
2. Cavalcante LL, Cavalcante ML, Murray TG, et al. Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis. Clin Ophthalmol. 2010;4:519-524.
3. Mason JO III, White MF, Feist RM, et al. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection. Retina. 2008;28(4):564-567. (Pubitemid 351589565)
4. Fintak DR, Shah GK, Blinder KJ, et al. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina. 2008;28(10):1395-1399.
5. Pilli S, Kotsolis A, Spaide RF, et al. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol. 2008;145(5):879-882.
6. Diago T, McCannel CA, Bakri SJ, Pulido JS, Edwards AO, Pach JM. Infectious endophthalmitis after intravitreal injection of antiangiogenic agents. Retina. 2009;29(5):601-605.
7. Scott IU, Edwards AR, Beck RW, et al. Diabetic Retinopathy Clinical Research Network. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology. 2007;114(10):1860-1867.
8. McCannel CA. Meta-analysis of endophthalmitis after intravitreal injection of antivascular endothelial growth factor agents: causative organisms and possible prevention strategies [published online February 17, 2011]. Retina. doi:10.1097/IAE.0b013e31820a67e4.
9. McLure HA, Talboys CA, Yentis SM, Azadian BS. Surgical face masks and downward dispersal of bacteria. Anaesthesia. 1998;53(7):624-626. (Pubitemid 28342392)
10. O'Kelly SW, Marsh D. Face masks and spinal anaesthesia. Br J Anaesth. 1993;70(2):239.
11. Philips BJ, Fergusson S, Armstrong P, Anderson FM, Wildsmith JA. Surgical face masks are effective in reducing bacterial contamination caused by dispersal from the upper airway. Br J Anaesth. 1992;69(4):407-408.
12. Alwitry A, Jackson E, Chen H, Holden R. The use of surgical facemasks during cataract surgery: is it necessary? Br J Ophthalmol. 2002;86(9):975-977. (Pubitemid 34953607)
13. Moss JM, Sanislo SR, Ta CN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology. 2009;116(8):1498-1501.
14. de Caro JJ, Ta CN, Ho HK, et al. Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections. Retina. 2008;28(6):877-883.
15. Baer ET. Post-dural puncture bacterial meningitis. Anesthesiology. 2006;105(2):381-393. (Pubitemid 44148184)
16. Trautmann M, Lepper PM, Schmitz FJ. Three cases of bacterial meningitis after spinal and epidural anesthesia. Eur J Clin Microbiol Infect Dis. 2002;21(1):43-45. (Pubitemid 34158505)
17. Veringa E, van Belkum A, Schellekens H. Iatrogenic meningitis by Streptococcus salivarius following lumbar puncture. J Hosp Infect. 1995;29(4):316-318.
18. Schneeberger PM, Janssen M, Voss A. Alpha-hemolytic streptococci: a major pathogen of iatrogenic meningitis following lumbar puncture: case reports and a review of the literature. Infection. 1996;24(1):29-33. (Pubitemid 26062734)
19. Shewmaker PL, Gertz RE Jr, Kim CY, et al. Streptococcus salivarius meningitis case strain traced to oral flora of anesthesiologist. J Clin Microbiol. 2010;48(7):2589-2591.
20. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(10)(suppl 2):S65-S164. (Pubitemid 350213178)
21. Tunevall TG. Postoperative wound infections and surgical face masks: a controlled study. World J Surg. 1991;15(3):383-388.
22. Webster J, Croger S, Lister C, Doidge M, Terry MJ, Jones I. Use of face masks by non-scrubbed operating room staff: a randomized controlled trial. ANZ J Surg. 2010;80(3):169-173.
23. Owens CD, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect. 2008;70(suppl 2):3-10.
24. Rosenfeld PJ, Brown DM, Heier JS, et al. MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419-1431. (Pubitemid 44511557)
25. Brown DM, Kaiser PK, Michels M, et al. ANCHOR Study Group. Ranibizumab vs verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432-1444. (Pubitemid 44511558)
26. Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ; CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011;364(20):1897-1908.